APPENDIX CANCER
Clinical trials for APPENDIX CANCER explained in plain language.
Never miss a new study
Get alerted when new APPENDIX CANCER trials appear
Sign up with your email to follow new studies for APPENDIX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug CBX-12 tested for Tough-to-Treat cancers
Disease control CompletedThis study tested a new drug called CBX-12 in 69 adults with advanced solid tumors (like ovarian, lung, breast, or colon cancer) that had stopped responding to standard treatments. The goal was to find a safe dose and see if the drug could shrink tumors. The study was completed, …
Matched conditions: APPENDIX CANCER
Phase: PHASE1, PHASE2 • Sponsor: Cybrexa Therapeutics • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
Smart dosing algorithm keeps chemo on track for cancer patients
Disease control CompletedThis study tested a new computer-based tool to help doctors adjust chemotherapy doses for people with cancers of the digestive system (like colorectal or stomach cancer). The goal was to reduce unplanned delays in treatment while keeping the dose strong enough to fight the cancer…
Matched conditions: APPENDIX CANCER
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated May 26, 2026 07:24 UTC